Hazy Regulations, Huge Reward

Wednesday, March 13, 2019

Rich Fama discussed with Marijuana Ventures the rise of CBD products and the lack of clarity at the federal level on regulating CBD. The manufacture and sale of CBD products remain legal gray areas, but companies are moving fast to establish their brands, jockeying for the advantage of being first-movers and capitalizing on the cannabidiol rush. Rich believes that we are, "going to see the FDA cracking down more significantly — products making health claims.”He also suggests avoiding any claims that a product could prevent, cure or diagnose a disease — including in pets, as those products are not immune from penalties related to false or deceptive claims, such as unsubstantiated medical benefits.

To read the full article, click here

Share on LinkedIn


Related Practice Areas

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.